Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
61.93
-1.97 (-3.08%)
At close: May 15, 2026, 4:00 PM EDT
61.74
-0.19 (-0.31%)
After-hours: May 15, 2026, 7:43 PM EDT

Oruka Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
49.5246.9461.5837.4342.4553.36
Short-Term Investments
339.31290.11314.07---
Cash & Short-Term Investments
388.83337.04375.6537.4342.4553.36
Cash Growth
11.38%-10.28%903.58%-11.81%-20.45%8.74%
Other Current Assets
6.426.811.220.160.251.06
Total Current Assets
395.25343.86376.8737.5942.754.42
Net Property, Plant & Equipment
2.012.121.040.260.370.49
Long-Term Investments
107.12142.5418.07---
Other Long-Term Assets
0.10.10.040.010.020.02
Total Assets
504.48488.62396.0237.8643.0954.92
Accounts Payable
3.664.163.460.360.331.12
Accrued Expenses
9.2910.593.350.280.172.38
Current Portion of Leases
0.680.620.21---
Other Current Liabilities
30.016.02-0.63-
Total Current Liabilities
16.6315.3713.040.641.133.5
Long-Term Leases
1.131.310.760.20.280.38
Total Long-Term Liabilities
1.131.310.760.20.280.38
Total Liabilities
17.7616.6913.80.841.413.88
Preferred Stock
2.932.932.93---
Common Stock
0.050.050.040.010.010.01
Additional Paid-in Capital
705.2657.56463.02225.75225.06224.51
Accumulated Other Comprehensive Income
-0.480.55-0.04---
Retained Earnings
-220.98-189.16-83.72-188.74-183.4-173.48
Shareholders' Equity
486.72471.93382.2237.0241.6751.04
Total Liabilities & Equity
504.48488.62396.0237.8643.0954.92
Total Debt
1.811.930.970.20.280.38
Net Cash (Debt)
387.02335.11374.6837.2342.1752.98
Net Cash Growth
15.49%-10.56%906.47%-11.71%-20.41%8.87%
Net Cash Per Share
7.907.3522.3230.9935.1145.72
Book Value
486.72471.93382.2237.0241.6751.04
Book Value Per Share
9.9410.3522.7730.8234.7044.05
Tangible Book Value
486.72471.93382.2237.0241.6751.04
Tangible Book Value Per Share
9.9410.3522.7730.8234.7044.05
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q